Complete clearance lasts for a very long time due to knockout of resident memory T cells within the skin,’ said the study’s ...

Mumbai: After completing two admission cycles, several city colleges that shifted to the All-India Council for Technical ...

Bristol Myers Squibb (BMY) is undervalued and poised for growth, with strong dividends and robust financials. Read here for ...

Pfizer could soon launch a multi-billion dollar bid for immunotherapy rivals Bristol-Myers Squibb. But moves into new fields of innovation and digital tech – such as Roche’s buyout of Flatiron - are ...

Bristol-Myers Squibb Company is rated a Buy with solid rebound and robust free cash flow margins. Learn more about BMY stock ...

Bristol Myers Squibb (BMY) ended the recent trading session at $54.19, demonstrating a +1.61% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a gain ...

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs ...

Cowtown is bringing pure decadence to the table this New Year’s Eve. The Mont is hosting a seven-course dinner featuring highlights like black truffle jalapeño gougère, scallop tartare with caviar, ...

Even as the Common Entrance Test (CET) for admissions to Bachelor of Management Studies (BMS) and Bachelor of Business Administration (BBA) courses were held twice this year, nearly 65% of seats in ...

BMS is spinning out a new company with five immunology assets, including oral drugs being developed for systemic lupus erythematosus and plaque psoriasis, and $300 million in funds from Bain Capital.